checkAd
    Xeris Biopharma Holdings Aktie
    1,8000
     
    EUR
    +2,74 %
    +0,0480 EUR
    Letzter Kurs 17:06:14 Tradegate
    1,7380
     
    EUR
    7.000 STK
    Geldkurs 20:24:04
    1,7990
     
    EUR
    3.800 STK
    Briefkurs 20:24:04
    ISIN: US98422E1038 · WKN: A3C4ZC · SYM: 2B30 · USA

    Neueste Nachrichten

    Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics
    13:00 Uhr · Business Wire (engl.) · Xeris Biopharma Holdings
    Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024
    02.05.24 · Business Wire (engl.) · Xeris Biopharma Holdings
    Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    03.04.24 · Business Wire (engl.) · Xeris Biopharma Holdings
    Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
    06.03.24 · Business Wire (engl.) · Xeris Biopharma Holdings
    Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
    06.03.24 · Business Wire (engl.) · Xeris Biopharma Holdings
    Fokus Aktien mit extremen Handelsvolumen am Montag, den 04.03.2024
    04.03.24 · wO Chartvergleich · Myriad Genetics
    Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
    28.02.24 · Business Wire (engl.) · Xeris Biopharma Holdings
    Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference
    05.02.24 · Business Wire (engl.) · Xeris Biopharma Holdings
    Xeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject Formulation of Teprotumumab
    10.01.24 · Business Wire (engl.) · Xeris Biopharma Holdings
    Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    05.01.24 · Business Wire (engl.) · Xeris Biopharma Holdings
    Xeris Biopharma Updates Its Outlook for 2023
    04.01.24 · Business Wire (engl.) · Xeris Biopharma Holdings
    Xeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    27.12.23 · Business Wire (engl.) · Xeris Biopharma Holdings